Gregory MacMichael

Gregory MacMichael

Nessuna posizione attualmente
70 anni
Health Technology
Consumer Services

Profilo

Gregory MacMichael is the founder of CMC BioServices LLC, which was founded in 2010.
He held former positions as Vice President at Wyeth LLC, Global Head-Biologics Development at Novartis AG, Senior Vice President-Process Development at Rocket Pharmaceuticals, Inc., Senior Vice President-Development & Manufacturing at NantKwest, Inc. from 2017 to 2018, and Senior Vice President-Technical Operations at Sio Gene Therapies, Inc. from 2018 to 2019.
He was also the Chief Technology Officer at Castle Creek Biosciences, Inc. from 2020 to 2021 and Chief Technical Officer at Coya Therapeutics, Inc. He received a doctorate from Mississippi State University, a graduate and doctorate degree from North Carolina State University, and an undergraduate degree from The Pennsylvania State University.

Precedenti posizioni note di Gregory MacMichael

SocietàPosizioneFine
SIO GENE THERAPIES INC. Corporate Officer/Principal 01/07/2019
IMMUNITYBIO, INC. Corporate Officer/Principal 01/09/2018
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2016
COYA THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Gregory MacMichael

Formazione di Gregory MacMichael

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

22

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

CMC BioServices LLC

  1. Mercati
  2. Insiders
  3. Gregory MacMichael